PCNA and neoplasm: However, this remains a complex matter to resolve because tumours can exploit NKp44 to escape NK cell recognition via expression of proliferating cell nuclear antigen to inhibit NK cell effector function86 and target cell lysis by NKp44 occurs only in combination with other activating receptors87.